MPH.L Share News (MPH)

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Mereo BioPharma To Acquire US Oncology Firm In All Stock Deal

LONDON (Alliance News) - Mereo BioPharma Group PLC on Wednesday said it will buy US oncology-focused clinical stage biopharmaceutical business OncoMed Pharmaceuticals Inc via a all-stock deal at a

Mereo BioPharma Doses First Patient In Phase Two MPH-966 Study

LONDON (Alliance News) - Rare disease pharmaceutical company Mereo Biopharma Group PLC said on Monday it has has dosed its first patient in its Phase 2 clinical study of MPH-966, which is for the

Mereo Completes Patient Enrolment In Brittle Bone Disease Drug Trial

LONDON (Alliance News) - Mereo Biopharma Group PLC on Monday said it has completed patient enrolment in its phase 2b clinical study of its drug BPS-804, or Setrusumab, which is being conducted in

Mereo BioPharma Completes Positive Revision Of Credit Facility Terms (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday that it completed a revision of the terms of its credit facility with Silicon Valley Bank and Kreos Capital.The revised terms

Mereo BioPharma Considering Fundraise As Interim Loss Narrows

LONDON (Alliance News) - Mereo BioPharma Group PLC said Wednesday it continues to make progress on "all fronts" after narrowing its interim loss.For the six months to June 30, the

UK Shareholder Meetings Calendar - Next 7 Days

Friday 15 JuneJD Sports Fashion (re acquisition of The Finish Line)MP Evans GroupBaker Steel 18 (re 19

Mereo BioPharma Looks To Broaden Shareholder Base (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Tuesday it placed 50,076 shares at 300 pence each.Following admission to trading of the new shares, which is expected to occur on 1,

Mereo BioPharma Halts Listing On Nasdaq Due To Market Conditions (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Thursday it has decided to postpone its proposed listing of American depository shares on the Nasdaq Global Market.Mereo said the

Mereo BioPharma Hails Positive BGS-649 Phase II Clinical Trial Data

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday it had received positive top-line data for its phase II clinical trial for hypogonadotropic hypogonadism in said

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Mereo Biopharma Progresses Drug Candidates In Maiden Interim Period

UK Shareholder Meetings Calendar - Next 7 Days

Mereo Biopharma Gets European Approval For Bone Disorder Treatment

Mereo Biopharma Shares Up 22% As It Starts Trading On AIM (ALLIPO)